Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) shares traded down 4.8% during mid-day trading on Thursday . The company traded as low as $35.07 and last traded at $35.15. 52,196 shares traded hands during trading, a decline of 91% from the average session volume of 611,880 shares. The stock had previously closed at $36.91. […]
Suvretta Capital Management LLC trimmed its stake in Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 24.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 616,480 shares of the biopharmaceutical company’s stock after selling 200,691 shares during the period. Suvretta Capital Management LLC owned 0.87% […]
Brokerages Set Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) Price Target at $81 21 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eleven research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company. The […]